Skip to main content

Unable to load price data. Sorry.


Immunomedics, Inc. (NASDAQ:IMMU.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:IMMU.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NeroSagetrade (82.64)
Submitted October 13, 2007

This is my ONE feel good story in my CAPS portfolio. I've followed Immunomedics for roughly six years and I've liked the direction management has taken the company in each successive year. They have never tried to mislead investors or the… More

zzlangerhans (99.94)
Submitted November 24, 2016

Surprisingly, my recent long bet on Immunomedics turned out to be a winner. Perhaps I have Trump to thank for that since I bought in shortly before the election surprise. Or perhaps I just got lucky: I've made a dozen bottom feeding picks in the last… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about IMMU.DL.

No one has written a Pitch for IMMU.DL stock yet. Tell us why you think IMMU.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in IMMU.DL.

No players have picked IMMU.DL yet. Tell us why you think IMMU.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for IMMU.DL.